Hinge Health Inc. HNGE
95.57
3.59
3.90%
as of 25 Sep
- Market cap
- $7.4B
- P/E
- 70.8×
Follow HNGE
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 41.44% | 316.76% | 345.72% | 0.00% |
+6 more TTM periods Free account |
|
| 14.12% | (140.34%) | (113.89%) | (118.50%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
61.47% | (373.47%) | (233.03%) | (147.03%) | |
Average Days of Receivables |
63.58 | 64.90 | 41.02 | 61.17 | |
Free Cash Flow per Share |
3.60 | 2.58 | 3.03 | 1.79 | |
Free Cash Flow |
283.92 | 202.76 | 165.38 | 141.48 | |
Capital Expenditures |
(6.86) | (6.84) | (6.06) | (4.40) | |
Piotroski F-Score |
5.00 | 1.00 | 1.00 | 1.00 | |
| Other line items | |||||
Cash ROIC |
39.63% | 49.02% | 31.60% | 21.20% | |
Accounts Receivable Turnover |
6.41 | 8.21 | 10.44 | 0.00 | |
Accounts Payable Turnover |
2.34 | 2.55 | 2.48 | 0.00 | |
Inventory Turnover |
7.26 | 9.91 | 8.27 | 0.00 | |
Average Days of Payables |
198.49 | 204.31 | 174.91 | 169.89 | |
Days of Inventory on Hand |
54.82 | 41.66 | 47.70 | 44.11 | |
Tax Rate |
(0.02) | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
17.93% | 58.02% | 62.62% | 69.37% | |
Selling, General and Administrative Expense of Revenue |
53.56% | 104.39% | 109.97% | 120.09% | |
Share Based Compensation of Revenue |
11.50% | 101.29% | 109.38% | 120.90% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
2.71 | (0.41) | (0.40) | (0.32) | |
Depreciation/Fixed assets |
5.30 | 5.21 | 4.97 | 5.64 | |
Capex/Depreciation |
(0.10) | (0.12) | (0.12) | (0.09) | |
Revenue per Share |
9.12 | 8.22 | 10.77 | 6.57 | |
Operating CF per Share |
3.68 | 2.67 | 3.14 | 1.85 | |
Capex per Share |
(0.09) | (0.09) | (0.11) | (0.06) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
14.91% | (79.12%) | (72.14%) | (88.09%) |
Columns are period end dates